Dianthus Therapeutics DNTH
NASDAQ DNTH
$88.21 -0.11 (-0.12%)
At close: Oct 2, 2026 · 4:00 PM EDT

Dianthus Therapeutics (DNTH) Change in Accured Expenses (2017 - 2025)

Updated

Dianthus Therapeutics' Change in Accured Expenses came in at $3 million for Q3 2025, down 46.8% from $5.65 million a year earlier and down 2.8% from the prior quarter.

Analysis

Dianthus Therapeutics (DNTH) Change in Accured Expenses (2017 - 2025) Analysis & Trends

Over the trailing twelve months to Sep 30, 2025, Dianthus Therapeutics reported Change in Accured Expenses of $6.87 million, down 8.5% year-over-year; for FY2024, it came in at $8.19 million.

  • Change in Accured Expenses carries a five-year compound annual growth rate of 10.0% (FY2019 to FY2024).
  • Going back by year, Change in Accured Expenses was $661,000 in FY2023 (-32.1%), $973,000 in FY2022 (+535.9%), $153,000 in FY2021 and -$3.63 million in FY2020.
  • The five-year range for quarterly Change in Accured Expenses is -$4.73 million (Q1 2023) to $5.65 million (Q3 2024).
  • Year-over-year, Change in Accured Expenses increased in four of the last six quarters, with growth averaging 105.8%.
  • The fastest year-over-year change in Change in Accured Expenses over five years came in Q3 2024 (growth of 631.0%), and the weakest in Q4 2020 (a decline of 93.1%).
  • Business Quant data shows DNTH's Change in Accured Expenses at $3.09 million (Q2 2025), -$1.5 million (Q1 2025) and $2.28 million (Q4 2024) in the three quarters before Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 2.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 1.20 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 338.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Dianthus Therapeutics 3.78 Bn 3.73 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 3.00 Mn
Jun 30, 2025 3.09 Mn
Mar 31, 2025 -1.50 Mn
Dec 31, 2024 2.28 Mn
Sep 30, 2024 5.65 Mn
Jun 30, 2024 3.25 Mn
Mar 31, 2024 -2.99 Mn
Dec 31, 2023 1.60 Mn
Sep 30, 2023 773,000.00
Jun 30, 2023 3.01 Mn
Mar 31, 2023 -4.73 Mn
Dec 31, 2022 1.52 Mn
Sep 30, 2022 936,000.00
Jun 30, 2022 -623,000.00
Mar 31, 2022 -859,000.00
Dec 31, 2021 -438,000.00
Sep 30, 2021 189,000.00
Jun 30, 2021 980,000.00
Mar 31, 2021 -578,000.00
Dec 31, 2020 255,000.00
API Access

Dianthus Therapeutics Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=DNTH&period=max&api_key=YOUR_API_KEY